Trizzino, M.; Gaudiano, R.; Arena, D.M.; Pipitò, L.; Gioè, C.; Cascio, A.
Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide Fumarate Regimen and Its Effect on Liver Steatosis Assessed by Fibroscan. Viruses 2025, 17, 440.
https://doi.org/10.3390/v17030440
AMA Style
Trizzino M, Gaudiano R, Arena DM, Pipitò L, Gioè C, Cascio A.
Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide Fumarate Regimen and Its Effect on Liver Steatosis Assessed by Fibroscan. Viruses. 2025; 17(3):440.
https://doi.org/10.3390/v17030440
Chicago/Turabian Style
Trizzino, Marcello, Roberta Gaudiano, Dalila Mimì Arena, Luca Pipitò, Claudia Gioè, and Antonio Cascio.
2025. "Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide Fumarate Regimen and Its Effect on Liver Steatosis Assessed by Fibroscan" Viruses 17, no. 3: 440.
https://doi.org/10.3390/v17030440
APA Style
Trizzino, M., Gaudiano, R., Arena, D. M., Pipitò, L., Gioè, C., & Cascio, A.
(2025). Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide Fumarate Regimen and Its Effect on Liver Steatosis Assessed by Fibroscan. Viruses, 17(3), 440.
https://doi.org/10.3390/v17030440